non-steroidal aromatase inhibitors

non-steroidal aromatase inhibitors

Drugs used to treat advanced breast cancer. Examples are aminoglutethimide (Orimeten), anastrozole (Arimidex) and letrozole (Femara).
References in periodicals archive ?
The trial of exemestane with and without entinostat evaluated 130 postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer, progressing on treatment with the non-steroidal aromatase inhibitors anastrozole or letrozole.
Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.
Results from a meta-analysis of the EFECT and SoFEA studies of fulvestrant and exemestane in metastatic breast cancer patients with acquired resistance to non-steroidal aromatase inhibitors.
ENCORE 301 (ENtinostat Combinations Overcoming REsistance) is a multicenter, randomized phase II study of exemestane with and without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer, progressing on treatment with the non-steroidal aromatase inhibitors anastrozole or letrozole.
Full browser ?